Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders

15 Oct 2015

Abstract excerpt

Neurodegenerative disorders are significantly increasing in incidence as the age of the global population continues to climb with improved life expectancy. At present, more than 30 million individuals throughout the world are impacted by acute and chronic neurodegenerative disorders with limited treatment strategies. The mechanistic target of rapamycin (mTOR), also known as the mammalian target of rapamycin, is a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to PI3K/AKT/mTOR signaling in cancer
Share to Sirtuins and Resveratrol in Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26469771
DOI: 10.1111/bcp.12804

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disordersPMID 26469771Read ↗

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegenerationSemantic proximity Read ↗

Taking aim at Alzheimer's disease through the mammalian target of rapamycinSemantic proximity Read ↗

Molecular neurobiology of mTORSemantic proximity Read ↗

The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disordersSemantic proximity Read ↗

mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in NeurodegenerationSemantic proximity Read ↗

Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1Semantic proximity Read ↗

Shedding new light on neurodegenerative diseases through the mammalian target of rapamycinSemantic proximity Read ↗

Advances in autophagy for Parkinson’s disease pathogenesis and treatmentSemantic proximity Read ↗

A Critical Kinase Cascade In Neurological Disorders: Pi3K, Akt and MtorSemantic proximity Read ↗

Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and ImmunotherapySemantic proximity Read ↗

mTOR Signaling in Parkinson's Disease.Semantic proximity Read ↗

mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.